Home
overview

SMi proudly presents the 8th annual COPD conference in London, 2016!
This event is about the developments made in the field of COPD.
COPD accounts for a substantial number of deaths in Great Britain: it has consistently given rise to between 25,000 and 30,000 deaths each year over the last 25 years*

Chronic and with a progressive worsening characteristic, COPD could present huge problems in the developed world with the increase in opportunistic infections and long-term infections, especially it is non-curable. As such, prevention, early diagnosis and patient monitoring are the only means to tame the disease.
Development of COPD has been slow despite the increase in cases. The 8th annual COPD conference will be dissecting the core issues and explore alternatives to accelerate treatment development!
 

*http://www.hse.gov.uk/Statistics/causdis/copd/copd.pdf

• Gain insight into formulation developments and the manufacturing of dry powder inhalation products
• Evaluate COPD and comorbidities
• Review the challenges in clinical trial designs and in drug development
• Learn about "first in class" inhaled drugs for the treatment of COPD and cystic fibrosis
• Explore recent advances made in COPD biomarkers

Job titles include but are not restricted to:
Chief Executives, Chief Scientific Officers, Vice Presidents, Heads, Directors, Prinicple Scientists, Associates, Project Leaders, Specialists, and Managers in the following areas:
Respiratory Physiology & Medicine
Respiratory Pharmacology
Medical Affairs
Inflammatory Disease
Respiratory, Inflammation and Autoimmunity
Pulmonary Disease
Respiratory Therapeutics
Immunology
Medical & Inhalation Devices
In-Vitro Biology
Biomarker
Inflammation Discovery
Preclinical R&D
Clinical Pharmacology
Clinical Trials
Clinical Science
Discovery
Global Data Informatics
Business Development
Brand Manager
Commercial
Respiratory Licensing & Regulation

A.Menarini Farmaceutica Internazionale; Actelion Pharmaceuticals; Aerocrine; Aptar Pharma; AstraZeneca; Boehringer Ingelheim; British Lung Foundation; Carclo Technical Plastics Ltd; Chiesi Farmaceutici S. P. A. ; Concert Pharmaceuticals; Elan Corp; GEFIM S.P.A.; GlaxoSmithKline; Glyconics; Hospital Sirio Libanes ; HRG GREECE; HUG; Imperial College London; Johnson and Johnson Pharmaceutical Services LLC; Medicines Evaluation Unit Ltd; MedImmune; National Union of Disabled Persons of Uganda NUDIPU; Novartis Pharma; Novartis Pharma AG; Osakidetza; Prosonix Ltd; Quintiles; Quintlies Ltd.; ResMed Sensor Technologies; SkyePharma; SMi Group Ltd; Teva UK Ltd; The Heart Lung Centre; Thomson Reuters; Truphone; ucl; University College London; University Hospital Geneva; University of the Basque Country; Verona Pharma; Vitalograph;

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Gary P. Anderson PhD FThorSoc FERS

Gary P. Anderson PhD FThorSoc FERS, Chief Scientist, Respiratory Inflammation and Autoimmunity iMed, AstraZeneca

9:10 Predicting drug efficacy using integrative models for chronic respiratory diseases

Jonathan Phillips

Jonathan Phillips, Principal Scientist, Amgen

  • Animal models are vital instruments of the drug discovery process
  • Novel bioinformatics methods
  • Innovative physiological techniques
  • 9:50 Blood eosinophils in COPD

    Mario Scuri

    Mario Scuri, Head Respiratory Unit, Chiesi Pharmaceuticals

  • Significance of blood eosinophils
  • Scientific evidence
  • The way forward
  • 10:30 Morning Coffee

    11:00 CASE STUDY: Patient selection strategies for clinical development of biologic drugs for COPD

    Donna Finch

    Donna Finch, Principal Scientist, MedImmune

  • Using patient selection strategies in COPD
  • Early clinical case studies using clinical phenotype, blood and lung biomarkers
  • 11:40 New approaches for COPD drug development: An opportunity for disease interception

    Christopher Stevenson

    Christopher Stevenson, Venture Leader, COPD Interception, Janssen Pharmaceutical Companies of Johnson & Johnson

  • Current therapies with long-acting bronchodilators and inhaled corticosteroids 
  • Alternative anti-inflammatories and bronchodilators
  • COPD interception: A new promising approach?
  • 12:20 Networking Lunch

    13:30 Recent advances in drug development & treatment of COPD

    Beverley Patterson

    Beverley Patterson, Associate Director, Inhalation Clinical, Actavis

  • Treatment options 
  •  Drug development strategies 
  • Insilco and PKPD modeling in the development of respiratory drugs
  • 14:10 Deconvoluting bioactive biomarkers to understand the pathogenesis of COPD exacerbations

    Gary P. Anderson PhD FThorSoc FERS

    Gary P. Anderson PhD FThorSoc FERS, Chief Scientist, Respiratory Inflammation and Autoimmunity iMed, AstraZeneca

    14:50 Afternoon Tea

    15:20 myCOPD an advanced patient self-management and rehabilitation platform

    Simon Bourne

    Simon Bourne, CEO, my Mhealth Limited

  • An introduction to online self management
  • Online vs. paper self management/class base pulmonary rehabilitation
  • myCOPD an international real-time patient platform to deliver population level care and research
  • 16:00 Targeting oxidant-dependent mechanisms for the treatment of COPD

    Ian Adcock

    Ian Adcock, Professor of Respiratory Cell and Molecular Biology, National Heart & Lung Institute

  • COPD overview 
  • Acute exacerbations of COPD
  • Oxidative stress in COPD
  • 16:40 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Donna Davies

    Donna Davies, Professor of Respiratory Cell and Molecular Biology, University Of Southampton

    9:10 COPD products: Trends and challenges

    Stephen Beckman

    Stephen Beckman, Head of Global Respiratory and Allergy, Mylan, Inc.

  • Drivers and penetration across different markets
  • Therapeutic positioning and need for cost savings
  • Effect of competition first to market opportunities
  • 9:50 Novel Anti-inflammatory for COPD : A billion dollar drug or a million dollar question?

    Neelima Khairatkar Joshi

    Neelima Khairatkar Joshi, Sr Vice President, Glenmark Pharmaceuticals

  • COPD Lung : Inflammation & Remodeling
  • Understanding Lung Pathology : Blind men - elephant story?
  • Novel targets and learning so far  
  • Is there light at the end of the tunnel?
  • 10:30 Morning Coffee

    11:00 Solithromycin is a next-generation oral and intravenous fluoroketolide

    Glenn Tillotson

    Glenn Tillotson, Senior Vice President of Medial Affairs, Cempra Pharmaceuticals

  • Profile of solithromycin
  • In vitro and in vivo studies
  • Small Phase II clinical trial of oral solithromycin in patients
  • 11:40 Advances in device and formulation technologies for pulmonary drug delivery

    Frank Thielmann

    Frank Thielmann, Lead New Inhalation Solids, Novartis Pharma AG

  • State of the art formulation strategy and technologies
  • Relevant physicochemical properties and how to measure them
  • Device – formulation interaction
  • Trends in device development
  • 12:20 Networking Lunch

    13:30 KEYNOTE ADDRESS: Mechanisms of virus-induced COPD exacerbations and novel treatment strategies

    Donna Davies

    Donna Davies, Professor of Respiratory Cell and Molecular Biology, University Of Southampton

  • Innate immune responses to viral infection in airways disease
  • The phenotype of COPD epithelium
  • Inhaled interferon-beta for treatment of COPD exacerbations
  • 14:10 Vitamin E isoform y-tocotrienol protects against cigarette smoke-induced experimental COPD

    W.S. Fred Wong

    W.S. Fred Wong, Associate Professor and Head of Pharmacology Department, National University Health System, Singapore

  • Oxidative stress and damage in COPD
  • Free radical-neutralizing capability of y-tocotrienol 
  • Anti-inflammatory properties of y-tocotrienol
  • 14:50 Afternoon Tea

    15:20 Cholinergic signalling, tiotropium and lung immunology: Impacts on COPD and asthma treatment

    Corinna Schnoeller

    Corinna Schnoeller, Research Associate, Imperial College London

  • Cholinergic signalling and the immune system
  • Impact on airway disease
  • Potential novel drug targets
  • 16:00 PANEL DISCUSSION: Developing clinical trials for COPD

    16:40 Chairman’s Closing Remarks and Close of Day Two

    +

    FEATURED SPEAKERS

    Donna Finch

    Donna Finch

    Principal Scientist, MedImmune
    Frank Thielmann

    Frank Thielmann

    Lead New Inhalation Solids, Novartis Pharma AG
    Mario Scuri

    Mario Scuri

    Head Respiratory Unit, Chiesi Pharmaceuticals
    Neelima Khairatkar Joshi

    Neelima Khairatkar Joshi

    Sr Vice President, Glenmark Pharmaceuticals
    Stephen Beckman

    Stephen Beckman

    Head of Global Respiratory and Allergy, Mylan, Inc.

    Beverley Patterson

    Associate Director, Inhalation Clinical, Actavis
    Beverley Patterson

    Christopher Stevenson

    Venture Leader, COPD Interception, Janssen Pharmaceutical Companies of Johnson & Johnson
    Christopher Stevenson

    Corinna Schnoeller

    Research Associate, Imperial College London
    Corinna Schnoeller

    Donna Davies

    Professor of Respiratory Cell and Molecular Biology, University Of Southampton
    Donna Davies

    Donna Finch

    Principal Scientist, MedImmune
    Donna Finch

    Frank Thielmann

    Lead New Inhalation Solids, Novartis Pharma AG
    Frank Thielmann

    Gary P. Anderson PhD FThorSoc FERS

    Chief Scientist, Respiratory Inflammation and Autoimmunity iMed, AstraZeneca
    Gary P. Anderson PhD FThorSoc FERS

    Glenn Tillotson

    Senior Vice President of Medial Affairs, Cempra Pharmaceuticals
    Glenn Tillotson

    Ian Adcock

    Professor of Respiratory Cell and Molecular Biology, National Heart & Lung Institute
    Ian Adcock

    Jonathan Phillips

    Principal Scientist, Amgen
    Jonathan Phillips

    Mario Scuri

    Head Respiratory Unit, Chiesi Pharmaceuticals
    Mario Scuri

    Neelima Khairatkar Joshi

    Sr Vice President, Glenmark Pharmaceuticals
    Neelima Khairatkar Joshi

    Simon Bourne

    CEO, my Mhealth Limited
    Simon Bourne

    Stephen Beckman

    Head of Global Respiratory and Allergy, Mylan, Inc.
    Stephen Beckman

    W.S. Fred Wong

    Associate Professor and Head of Pharmacology Department, National University Health System, Singapore
    W.S. Fred Wong

    Supporters

    VENUE

    Holiday Inn Kensington Forum

    97 Cromwell Road , London, United Kingdom

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    Media Partners


    Copybook - Pharmaceutical

    Supporters
    http://www.copybook.com/pharmaceutical

    Copybook is a global business network with many pharmaceutical events, exhibitions and seminars. We encourage business-to-business transactions and work tirelessly to gain our customers new business contracts worldwide. You can add events, companies and associations for free. When you are a member, you can add your company to the events listed in order to encourage other visitors to arrange meetings and appointments at those events to facilitate new business contracts. Want to see how we can increase your business network and transactions? SIGN UP FOR FREE today! Copybook – Your Global Business Network


    Labhoo

    Supporters
    http://www.labhoo.com



    PharmaVOICE

    Supporters
    http://www.pharmavoice.com

    PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 41,000 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.


    ASD MEDIA

    Supporters
    http://www.asd-network.com

    Professionals in the Aerospace & Defence market use the ASD Media internet platforms to:
    • Be informed on the latest market developments; www.asd-network.com
    • Find the latest business news; www.asd-network.com
    • Find the upcoming events; www.asd-network.com
    • Find companies and organizations; www.asdsource.com
    • Distribute news globally. www.asdwire.com
    The ASD Media platforms are well known and used intensively, your company is able to benefit from these large numbers of users. Be informed with ASD-Network; Create exposure for your company with ASDSource, distribute your news with ASDWire or advertise with us, build your brand and increase traffic to your company’s website.

    For more detailed information please contact with: ASD MEDIA
    Stefan.koopman@asdmedia.nl


    GBI

    Supporters
    http://www.gbihealth.com/

    GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.


    Pharmacircle

    Supporters
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    Pharmavision

    Supporters
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


    Taylor & Francis Group

    Supporters
    http://bit.ly/TF-Med

    As one of the world’s leading publishers of scholarly journals, books, eBooks, reference works, and databases, Taylor & Francis Group partners with researchers, scholarly societies, universities, and libraries worldwide to bring knowledge to life.


    Lab Bulletin

    Supporters
    http://www.labbulletin.com

    Lab Bulletin is a free online resource for scientists and laboratory professionals where you can catch up on the latest news for laboratory products and services. You will find an extensive directory of laboratory suppliers and manufacturers enabling you to contact companies quickly and easily to request further information. Lab Bulletin also publishes four free monthly E-Newsletters keeping you up-to-date with all of the latest laboratory products and industry news directly to your inbox. We have dedicated E-Newsletters for Chromatography and Spectroscopy, Microscopy and Image Analysis, weekly Industry News updates and our monthly Lab Bulletin E-Newsletter sent out to over 29,000 readers worldwide. To request your free copy click here


    Inderscience Publishers

    Supporters
    http://www.inderscience.com

    Inderscience is a dynamic, leading, independent journal publisher. The company disseminates the latest research across the broad fields of science, engineering and technology; management, public and business administration; environment, ecological economics and sustainable development; computing, ICT and internet/web services, and related areas. Inderscience offers over 35 years' experience in publishing and has succeeded in building a substantial collection approaching 400 high-quality peer-reviewed international research journals in both online and print formats. We offer a variety of ways to keep up-to-date with the latest published leading-edge research while our online collection represents a fully-searchable digital archive of around 60,000 articles.


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    Swiss Biotech Association

    Supporters
    http://www.swissbiotech.org/

    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


    EIN News

    Supporters
    http://www.einnews.com

    EIN News is the world leader in industry focused online news monitoring. Thousands of leading companies, institutions and global professionals from business, industry, and government rely on EIN News as an indispensable resource. Our systems continuously scan the web, indexing news from thousands of worldwide sources. The news you need is then organized by advanced software systems managed by a team of professional news editors. Everything we do is focused on streamlining your news searches and research in order to save you time and money.


    Select Science

    Supporters
    http://www.selectscience.net/

    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover impartial, expert opinion and trusted reviews about latest laboratory equipment and techniques; plus videos, application notes and science news from around the world. Become a member for free today.


    Pharmavision

    Supporters
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


    Farmavita

    Supporters
    http://www.farmavita.net/

    Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers
    Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Holiday Inn Kensington Forum

    97 Cromwell Road
    London SW7 4DN
    United Kingdom

    Holiday Inn Kensington Forum

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.